Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT03091634 | The Efficacy and Safety of the Xue-Fu-Zhu-Yu Capsule in Treatment of Qi Stagnation and Blood Stasis Syndrome. | PHASE2 | COMPLETED | 120 | — | — | May 6, 2017 | Dec 31, 2018 | Nov 26, 2019 | 3 | China |
The Traditional Chinese Medicine PRO scale includes physiological domain,psychological domain,independence and social domain. And the change of the total score of the Traditional Chinese Medicine PRO Scale in Patients of QS\&BSS will be assessed.
| Arm | Type | Description |
|---|---|---|
| test group | EXPERIMENTAL | the patients in this group take 6 xue-fu-zhu-yu capsules once, twice a day, for 7weeks. |
| control group | PLACEBO_COMPARATOR | the patients in this group take 6 xue-fu-zhu-yu capsule simulated agents once, twice a day, for 7weeks.. |
| Name | Type | Description |
|---|---|---|
| xue-fu-zhu-yu capsule | DRUG | participants are given to 6 xue-fu-zhu-yu capsule per time, twice a day. The duration is 7 weeks |
| xue-fu-zhu-yu capsule simulated agent | DRUG | participants are given to 6 xue-fu-zhu-yu capsule simulated agent per time, twice a day. The duration is 7 weeks |
Inclusion Criteria: * The participants diagnosed as QS\&BSS; * The age of participants is from 18 to 65; * Participants who voluntarily signed informed consent. Exclusion Criteria: * Participants with other obvious Chinese medicine syndrome * Participants diagnosed as acute myocardiac infarction,...